Japan · 
What does Atalanta Therapeutics invest in?
Atalanta Therapeutics invests most often at Series A and Series D (80% of the rounds on record), in sectors such as Biotechnology and Life Science.
Atalanta Therapeutics highlights
- 01
8 rounds on record
- 02
Mostly Series A and Series D: 80% of its rounds
- 03
Sole investor in 2 rounds, median $7.0M
- 04
3 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- BiotechnologyLife Science
- Based in
- Hook, Japan
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first8 appearances
- 2024
1 round
- Dec
- 2019
2 rounds
- Nov
- Sept
- 2010
1 round
- Jul
- 2001
1 round
- Jan
- 2000
2 rounds
- Aug
- Mar
- 1999
1 round
- Dec
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed3 in all
DeNABought by peroliUndisclosedOct 2014
DeNAListedUndisclosedFeb 2005
Silicon WaveBought by RFMDUndisclosedApr 2004
An exit counts when it came after the firm's first round in the company. From historical deal records.